PCROWD NEWS

Katie Couric Helps Spread the Word About Why Blood Cancer is Often Diagnosed Too Late

See the Story on Katie Couric's Website here. Katie Couric has spent many years advocating for patients with cancer. In a recent...

Tom Brokaw - Shining a Light on Early Diagnosis Options

Tom Brokaw was diagnosed with Multiple Myeloma (MM) in 2013. Since then, he's made it his mission to raise awareness about MM and support...

Ask A Multiple Myeloma Expert - Public Webinar Series Pt. 1

Welcome to a 3-part series for patients living with blood cancer or its precursor conditions, and their families, including those...

Ask An Expert II: The Myeloma Spectrum and COVID-19

Listen in to our physicians' discussion on the impacts of COVID-19 on multiple myeloma and precursor condition treatment plans,...

Ask An Expert, Public Webinar Part 3 - Multiple Myeloma, the FDA, and the Future with COVID-19

The patient support discussion will be based around importance of early cancer screening for people at risk, health disparities in...

Latest Medical Findings - Genomic Profiling and Smoldering Myeloma

Our team publishes myeloma research to share findings and improve treatment for everyone who has myeloma-related conditions. We are...

Publication - The Risk Factors of Progression in Asymptomatic WM

Study Link is here - (Originally published in the Journal of Clinical Oncology) We are grateful to our community of supporters in the...

Research Update - Predicting Progression in Multiple Myeloma

Mark Bustoros, MD, discusses how the use of genomic predictors in multiple myeloma (MM) allows for a better understanding of who will...

Meet Dr. Mark Bustoros - Researcher on Blood Cancer Precursor Condition Research

Learn more about PCROWD and the ongoing research on precursor conditions. Video - 2:35 minutes In this interview with Mark Bustoros, MD...

Research Updates on Smoldering Multiple Myeloma - Dr. Mark Bustoros

Video: 30:34 Minutes A Professional Presentation From Dana-Farber Cancer Institute Mark Bustoros, MD of the Dana Farber Cancer Institute,...

Smoldering Multiple Myeloma - To Treat Or Not To Treat

VIDEO: 3:26 Minutes Even when people are not experiencing symptoms, it is important to consider the outcomes research when deciding...

Stand Up To Cancer Funds Boston Research, Clinical Trials For Patients

BOSTON (CBS) – Fighting cancer one contribution at a time, that’s what’s happening Friday night on Channel 4 and on the other TV networks...

Honoring a decade of Standing Up To Cancer

On September 7, Stand Up To Cancer’s (SU2C) telecast shared inspiring stories of hope, perseverance, and groundbreaking cancer research...

Ben Ebert "The future of cancer prevention"

Ben Ebert is a physician and scientist focusing on the biology of leukemia and genetic mutations that cause cancers. He directs research...

Finding Cures Together: The Dream Team for Blood Cancer Research

CHICAGO – April 15, 2018 -- Stand Up To Cancer announced a $10 million award to a Stand Up To Cancer Dream Team focused on...

Genetic Landscape of Smoldering Multiple Myeloma

Mark Bustoros, MD, provides insight on prognostic models in smoldering multiple myeloma (SMM) and genetic mutations that are associated...

Center of Prevention of Progression of Blood Cancers and PCROWD

January 23, 2018 - Mark Bustoros, MD from Dana-Farber Cancer Institute discusses the Center for Prevention of Progression of Blood...

Improving the prediction of progression of multiple myeloma

Mark Bustoros, MD from Dana-Farber Cancer Institute discusses on how to improve the prediction of progression of multiple myeloma at the...

Liquid biopsies in patients with multiple myeloma precursor conditions

Mark W. Bustoros, MD, a postdoctoral fellow at Dana-Farber Cancer Institute, Harvard Medical School, discusses ongoing research exploring...

Irene Ghobrial, MD talks about genomic aberrations

In this video at ASH 2017, Irene Ghobrial, MD describes the research and recent discoveries that have been possible thanks to PCROWD...